Division of Healthcare Quality Promotion, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia (Mr Franklin and Drs Crist, Perkins, and Perz); and Northrop Grumman, Atlanta, Georgia (Mr Franklin).
J Public Health Manag Pract. 2022;28(2):116-125. doi: 10.1097/PHH.0000000000001148.
The Centers for Disease Control and Prevention awarded $85 million to health care-associated infection and antibiotic resistance (HAI/AR) programs in March 2015 as part of Infection Control Assessment and Response (ICAR) activities in the Epidemiology and Laboratory Capacity cooperative agreement Domestic Ebola Supplement.
One goal of this funding was to assess and improve program capacity to respond to potential health care outbreaks (eg, HAI clusters). All 55 funded programs (in 49 state and 6 local health departments) participated.
The Centers for Disease Control and Prevention developed guidance and tools for HAI/AR programs to document relevant response capacities, assess policies, and measure progress. HAI/AR programs completed an interim assessment in 2016 and a final progress report in 2017.
During the project period, 78% (n = 43) of the programs developed new investigation tools, 85% (n = 47) trained staff on outbreak response, and 96% (n = 53) of the programs reported hiring staff to assist with outbreak response activities. Staffing and expertise to support HAI outbreak response increased substantially among awardees reporting staffing limitations on the interim assessment, including in domains such as on-site infection control assessment (n = 20; 83%), laboratory capacity (n = 20; 91%), and data management/analytics (n = 14; 67%). By 2017, reporting requirements in 100% of the programs addressed possible HAI/AR outbreaks; 93% (n = 51) also addressed sentinel events such as identification of novel AR threats. More than 90% (n = 50) of programs enhanced capacities for tracking response activities; in 2016, these systems captured 6665 events (range, 3-1379; median = 46). Health departments also reported wide-ranging efforts to engage regulatory, public health, and health care partners to improve HAI/AR outbreak reporting and investigation.
Broad capacity for responding to HAI/AR outbreaks was enhanced using Ebola ICAR supplemental funding. As response activities expand, health department programs will be challenged to continue building expertise, reporting infrastructure, investigation resources, and effective relations with health care partners.
美国疾病控制与预防中心于 2015 年 3 月向与医疗保健相关的感染和抗生素耐药性（HAI/AR）项目拨款 8500 万美元，这是传染病控制评估和响应（ICAR）活动的一部分，该活动是流行病学和实验室能力合作协议国内埃博拉补充协议的一部分。
这项资金的目标之一是评估和提高应对潜在医疗保健疫情（例如，HAI 集群）的项目能力。所有 55 个受资助项目（在 49 个州和 6 个地方卫生部门）都参与了。
美国疾病控制与预防中心为 HAI/AR 项目制定了指导方针和工具，以记录相关的应对能力，评估政策，并衡量进展。HAI/AR 项目在 2016 年完成了中期评估，并在 2017 年完成了最终进展报告。
在项目期间，78%（n=43）的项目开发了新的调查工具，85%（n=47）对疫情应对人员进行了培训，96%（n=53）的项目报告称雇用了工作人员协助疫情应对活动。在中期评估中报告人员配备限制的受助者中，HAI 疫情应对的人员配备和专业知识大幅增加，包括现场感染控制评估（n=20；83%）、实验室能力（n=20；91%）和数据管理/分析（n=14；67%）等领域。到 2017 年，所有项目都报告了 100%的可能的 HAI/AR 疫情报告要求；93%（n=51）还报告了新出现的 AR 威胁等哨点事件。超过 90%（n=50）的项目增强了跟踪应对活动的能力；在 2016 年，这些系统共捕获了 6665 起事件（范围为 3-1379；中位数为 46）。卫生部门还报告了广泛的努力，以吸引监管、公共卫生和医疗保健合作伙伴，以改善 HAI/AR 疫情报告和调查。
利用埃博拉补充 ICAR 资金，广泛提高了应对 HAI/AR 疫情的能力。随着应对活动的扩大，卫生部门的项目将面临继续建立专业知识、报告基础设施、调查资源以及与医疗保健合作伙伴建立有效关系的挑战。
